What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Neuron
Reinhard Schliebs mostly deals with Internal medicine, Endocrinology, Cholinergic, Pathology and Basal forebrain.
His studies deal with areas such as Signal transduction and Neuroscience as well as Internal medicine.
Reinhard Schliebs interconnects Tau protein and Amyloid in the investigation of issues within Endocrinology.
His studies in Cholinergic integrate themes in fields like AMPA receptor and Acetylcholine.
His Pathology research is multidisciplinary, incorporating elements of Hippocampal formation, Interleukin and Genetically modified mouse.
His work deals with themes such as Nerve growth factor, Lesion and Cholinergic neuron, which intersect with Basal forebrain.
His most cited work include:
- The cholinergic system in aging and neuronal degeneration. (644 citations)
- The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. (396 citations)
- β-Amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology (244 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Cholinergic, Internal medicine, Endocrinology, Neuroscience and Basal forebrain.
The Cholinergic study combines topics in areas such as Acetylcholine, Amyloid precursor protein and Cell biology.
His Amyloid precursor protein research is multidisciplinary, incorporating perspectives in Molecular biology and Senile plaques.
His work focuses on many connections between Endocrinology and other disciplines, such as Acetylcholine receptor, that overlap with his field of interest in Nicotinic agonist.
Reinhard Schliebs combines subjects such as GABA receptor and GABAA receptor with his study of Neuroscience.
The various areas that Reinhard Schliebs examines in his Basal forebrain study include Hippocampal formation, Traumatic brain injury, In situ hybridization and Nerve growth factor.
He most often published in these fields:
- Cholinergic (44.51%)
- Internal medicine (43.35%)
- Endocrinology (43.35%)
What were the highlights of his more recent work (between 2007-2020)?
- Endocrinology (43.35%)
- Internal medicine (43.35%)
- Amyloid precursor protein (23.12%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Endocrinology, Internal medicine, Amyloid precursor protein, Cholinergic and Alzheimer's disease.
Reinhard Schliebs has researched Endocrinology in several fields, including Neurodegeneration, Pathogenesis and Amyloid.
His work on Deficient mouse, Long-term potentiation and Neuropeptide as part of his general Internal medicine study is frequently connected to Neprilysin, thereby bridging the divide between different branches of science.
His research integrates issues of Molecular biology, Genetically modified mouse, Biochemistry and Cell biology in his study of Amyloid precursor protein.
His study in the fields of Cholinergic neuron and Basal forebrain under the domain of Cholinergic overlaps with other disciplines such as Cytosol.
His Alzheimer's disease research includes themes of Cerebral cortex, Ginkgo biloba and Hippocampus.
Between 2007 and 2020, his most popular works were:
- The cholinergic system in aging and neuronal degeneration. (644 citations)
- Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy (209 citations)
- Insulin-Resistant Brain State after Intracerebroventricular Streptozotocin Injection Exacerbates Alzheimer-like Changes in Tg2576 AβPP-Overexpressing Mice (93 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Neuron
- Internal medicine
His primary areas of study are Internal medicine, Endocrinology, Genetically modified mouse, Amyloid precursor protein and Pathology.
Reinhard Schliebs conducted interdisciplinary study in his works that combined Internal medicine and Streptozotocin.
His research in Endocrinology intersects with topics in Apoptosis, Beta and Tau protein.
His study in Genetically modified mouse is interdisciplinary in nature, drawing from both Molecular biology, Neuroprotection and Senile plaques.
Amyloid precursor protein is a subfield of Alzheimer's disease that Reinhard Schliebs studies.
His Alzheimer's disease study incorporates themes from Cholinergic Fibers, Cholinergic neuron, Hippocampus and Nicotinic acetylcholine receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
